Sana Karam, Vice Chair of Translational Research at University of Colorado School of Medicine, shared a post on X about a paper she co-authored with colleagues published in JITC:
“New from Karam Lab.
TME dictates response to RT-IO:
Tumor response vs progression using identical radiation-immunotherapy regimen is independent of cancer cell type but rather mediated by the TME and Tregs accumulation.”
Authors: Jacob Gadwa, Justin Yu, Miles Piper, Maria Amann, Sana Karam et al.
More posts featuring Sana Karam.